Instylla's Embrace Hydrogel Embolic System minimizes bleeding risks during the embolization of hypervascular tumors in the peripheral arteries.

Plaintiffs in the complaint include Radiology Partners and its affiliates, the Arkansas-based Highlands Oncology Group and Harvard Medical Faculty Physicians. 

Customers with these devices on hand are asked to return them right away. No serious injuries have been reported at this time, but the presence of residual particulates can lead to such side effects as pulmonary embolism and deep vein thrombosis.

The number is almost double initial estimates. With final data breach notifications now sent, UnitedHealthcare said its investigation into the February 2024 ransomware attack is coming to a close.

Secretary of Health and Human Services Robert F. Kennedy Jr. says the agency is winding down support for mRNA as it looks to "whole virus" vaccines that offer broad protection against seasonal illnesses such as COVID-19 and influenza.

Because of this risk, which has been associated with 120 serious injuries, Boston Scientific is updating the instructions for use of several Watchman access systems.

Boston Scientific manufactured these devices from 2002 to 2021, and approximately 354,000 are still in use. It is recommended that clinicians look for early signs of this issue during scheduled follow-up appointments.

The question of legal responsibility for AI gone wrong in healthcare remains unsettled. The only sure thing is a lot of finger pointing.